Publications by authors named "Balaguru Ravikumar"

Claim this Profile
L
Leveraging multiple data types for improved compound-kinase bioactivity prediction.
Ryan Theisen, Tianduanyi Wang, Balaguru Ravikumar, Rayees Rahman, Anna Cichońska

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI for targeted polypharmacology: The next frontier in drug discovery.
Anna Cichońska, Balaguru Ravikumar, Rayees Rahman

Curr Opin Struct Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the conformational landscape of AlphaFold2-predicted protein kinase structures.
Carmen Al-Masri, Francesco Trozzi, Shu-Hang Lin, Oanh Tran, Navriti Sahni, Balaguru Ravikumar

Bioinform Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells.
Paschalis Athanasiadis, Balaguru Ravikumar, Richard J R Elliott, John C Dawson, Neil O Carragher

iScience· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crowdsourced mapping of unexplored target space of kinase inhibitors.
Anna Cichońska, Balaguru Ravikumar, Robert J Allaway, Fangping Wan, Sungjoon Park

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal: Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of .
Indresh Kumar Maurya, Chaitanya Kumar Thota, Sachin Dev Verma, Jyotsna Sharma, Manpreet Kaur Rawal, Balaguru Ravikumar

J Biol Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
Balaguru Ravikumar, Sanna Timonen, Zaid Alam, Elina Parri, Krister Wennerberg

Cell Chem Biol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Balaguru Ravikumar, Tero Aittokallio

Expert Opin Drug Discov· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.
Jing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, Zaid Alam, Anni Rebane

Cell Chem Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles.
ZiaurRehman Tanoli, Zaid Alam, Markus Vähä-Koskela, Balaguru Ravikumar, Alina Malyutina

Database (Oxford)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.
Anna Cichonska, Balaguru Ravikumar, Elina Parri, Sanna Timonen, Tapio Pahikkala

PLoS Comput Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms.
Balaguru Ravikumar, Zaid Alam, Gopal Peddinti, Tero Aittokallio

Nucleic Acids Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
Indresh Kumar Maurya, Chaitanya Kumar Thota, Sachin Dev Verma, Jyotsna Sharma, Manpreet Kaur Rawal, Balaguru Ravikumar

J Biol Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis